Skip to content
DataLookout
Menu

NCT06713070

Role of Gait Analysis in Different Type of Dementia

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary endpoint(s) modified Show 8 more changesShow less
    • Eligibility criteria shortened, about 6 words
    • Completed without a posted recruiting period
    • Primary completion date changed from estimate of May 2025 to Nov 15, 2025
    • Study sites: 0 to 1
    • Study completion date changed from estimate of Oct 2025 to Jan 10, 2026
    • Start date changed from estimate of Dec 2024 to Dec 12, 2024
    • Secondary endpoints expanded, about 21 words
    • Publications: details revised at 16 of 17 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Gait Speed
Timeframe: Baseline assessment.
Gait Symmetry
Timeframe: Baseline assessment.

Secondary (7)

Berg Balance Scale
Dynamic Gait Index
Timed Up and Go Test .
Timed 25-Foot Walk Test
Stride Length
Show 2 moreShow less
Cadence
Stride Duration

Arms and interventions

Cohort 1 (Dementia)

The group that will contain the diseased participants (Dementic patients able to walk and perform gait analysis)

Sites

1 site in 1 country

  • Assiut University HospitalsAsyut, Assiut Governorate, Egypt